Minghui Pharmaceutical (hangzhou) Ltd

This phase 2 trial tested an ointment called MH004 in 156 people with non-segmental vitiligo, a condition that causes white patches on the skin. Participants applied the ointment to affected areas once or twice daily for 24 weeks. The study measured how much skin color returned, …

This Phase 3 study tested MH004 ointment in 375 adolescents and adults with mild to moderate atopic dermatitis (eczema). Participants applied the ointment or a placebo twice daily for 4 weeks, followed by a 44-week safety extension. The main goals were to see if the ointment coul…

This study tested an ointment called MH004 in 160 healthy volunteers and people with mild to moderate atopic dermatitis (eczema). The goal was to check safety and how well it reduces skin symptoms like redness and itching. The ointment was applied to the skin daily for several we…